The anti-epileptic drug Epanutin will be out of stock until November in its 50mg Infatabs (phenytoin base) form due to manufacturing delays, Pfizer has announced.
Related Article: Updated NHS App to help patients manage prescriptions
The pharma company revealed that the drug, which is used to control tonic-clonic seizures and partial seizures or both, had fallen victim to delays ‘despite best efforts’.
It said: ‘Phenytoin is a Category 1 anti-epileptic drug (AED). The active ingredient in Epanutin 50mg Infatabs and Dilantin 50mg Infatabs is the same, however in the absence of bioequivalence data, there may be clinically relevant differences between the two products.
‘Any switches to different presentations must be managed under medical supervision and monitoring of phenytoin serum levels to ensure the correct dosage is being given.’
Related Article: Pharmacy First proves popular with public but supply issues cause concern
While the oral suspension of the drug remains available, supplies are only sufficient to meet market demand and therefore patients should not be switched to this preparation, so as not to cause a shortage of this as well, Pfizer stressed.
Full information on the shortage and the recommended equivalent – including information for prescribers – can be found here.
Related Article: Starmer touts pharmacy-led weight loss jab drive in 10-year plan speech
Join our #WarOnShortages. Tweet us with information on how shortages are affecting your patients and business @Pharmacist_News or email [email protected]
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.